👤 Format: English, Hybrid (in-person attendance is strongly encouraged)
🗓️ Date & Time: 19.02.2026, Thursday – 6 pm
📍 Location: DKFZ Communication Center, Seminar Room K1/K2 Speaker: Francesco Cortopassi, Ph.D. - Business Development Manager
Discover the latest trends in cancer target validation and learn how next-generation humanized mouse models help researchers move faster, work smarter, and get closer to the clinic. This dynamic session highlights in vivo models, ADC-focused platforms, and real-world case studies supporting preclinical cancer research, from target discovery to translational validation.
Biocytogen is a global biotech company advancing antibody drug discovery through innovative platforms. Its RenBiologics™ portfolio delivers fully human antibody modalities across 1,000+ targets, while BioMice™ offers 4,000+ humanized models and integrated in vivo, ex vivo, and in vitro pharmacology and gene-editing services.
See you on the 19th of February!
